Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Aziyo Biologics (ELUT) is now available.
Elutia Inc. announced that their new product, EluPro®, previously known as CanGaroo®RM, has received FDA clearance. This antibiotic-eluting bioenvelope represents a significant milestone for the company, potentially impacting its stock as it marks a major regulatory success. The announcement could signal a positive shift for investors and those tracking the pharmaceutical sector.
Learn more about ELUT stock on TipRanks’ Stock Analysis page.